L-Alanyl/L-Glutamine — Competitive Intelligence Brief

L-Alanyl/L-Glutamine (L-Alanyl/L-Glutamine) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino acid supplement / Nutritional therapeutic. Area: Critical Care / Nutritional Support.

phase 3 Amino acid supplement / Nutritional therapeutic Critical Care / Nutritional Support Small molecule

Target snapshot

L-Alanyl/L-Glutamine (L-Alanyl/L-Glutamine) — University Hospital Muenster. L-Alanyl/L-Glutamine is a dipeptide that provides essential amino acids to support protein synthesis and cellular metabolism, particularly in critically ill or nutritionally compromised patients.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
L-Alanyl/L-Glutamine TARGET	L-Alanyl/L-Glutamine	University Hospital Muenster	phase 3	Amino acid supplement / Nutritional therapeutic
keto-amino acids	keto-amino acids	YUAN Wei-jie	marketed	Amino acid supplement / Nutritional therapeutic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Amino acid supplement / Nutritional therapeutic class)

1. University Hospital Muenster · 1 drug in this class
2. YUAN Wei-jie · 1 drug in this class